Company filings profile · CIK 0001828673

HCW Biologics Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for HCW Biologics Inc. (HCWB): 28 filings in the last 90 days vs 17 in the prior 90 (filing-velocity rising ↑ · 1.65×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.

Material 8-K events — HCW Biologics Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Jun 16, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 15, 2026Item 5.07
Jun 1, 2026Delisting / Listing-Rule Failure
May 27, 2026Termination of a Material Agreement; Financial Statements and Exhibits
May 21, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
May 14, 2026Results of Operations (earnings); Financial Statements and Exhibits
Apr 30, 2026Other Events; Financial Statements and Exhibits
Apr 30, 2026Other Events; Financial Statements and Exhibits
Apr 16, 2026Amendments to Bylaws/Charter; Financial Statements and Exhibits
Mar 31, 2026Results of Operations (earnings); Financial Statements and Exhibits
Mar 17, 2026Entry into a Material Agreement; Financial Statements and Exhibits
Mar 2, 2026Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Feb 19, 2026Entry into a Material Agreement; Regulation FD Disclosure; Other Events
Feb 13, 2026Entry into a Material Agreement; Financial Statements and Exhibits

Watch HCW Biologics Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
May 27, 20264
May 27, 20264
May 27, 20264

Recent filings

FiledFormDetail
Jun 18, 2026S-1/A S-1/A
Jun 16, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 15, 20268-K Item 5.07
Jun 8, 2026D Item 06b
Jun 8, 2026S-1 S-1
Jun 1, 20268-K Delisting / Listing-Rule Failure
May 27, 20264 4
May 27, 20264 4
May 27, 20264
May 27, 20268-K Termination of a Material Agreement; Financial Statements and Exhibits
May 21, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
May 18, 2026POS AM POS AM
May 15, 2026SCHEDULE 13G/A
May 14, 202610-Q 10-Q
May 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
May 13, 2026POS AM POS AM
Apr 30, 20268-K Other Events; Financial Statements and Exhibits
Apr 30, 20268-K Other Events; Financial Statements and Exhibits
Apr 29, 2026EFFECT Item ; Item ; Item
Apr 28, 2026DEF 14A DEF 14A
Apr 28, 2026ARS ARS
Apr 24, 2026S-1/A S-1/A
Apr 23, 2026S-1 S-1
Apr 17, 2026PRE 14A PRE 14A
Apr 16, 20268-K Amendments to Bylaws/Charter; Financial Statements and Exhibits
Apr 13, 2026DRS
Mar 31, 202610-K 10-K
Mar 31, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Mar 17, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Mar 13, 2026DEF 14A DEF 14A
Mar 3, 2026PRE 14A PRE 14A
Mar 2, 20268-K Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Feb 19, 20268-K Entry into a Material Agreement; Regulation FD Disclosure; Other Events
Feb 19, 2026424B4 424B4
Feb 17, 2026EFFECT Item ; Item ; Item
Feb 17, 2026SCHEDULE 13G
Feb 17, 2026S-1/A S-1/A
Feb 13, 2026S-1/A S-1/A
Feb 13, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Feb 11, 2026CORRESP